NCT07118189

Brief Summary

The overarching goal of this project is to conduct a pilot intervention in high-risk Kaiser Permanente Northern California patients with chronic obstructive pulmonary disease to mitigate their exposure to poor air quality and decrease exacerbations of lung disease.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Oct 2025Dec 2026

First Submitted

Initial submission to the registry

August 5, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

October 7, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

November 20, 2025

Status Verified

November 1, 2025

Enrollment Period

1.2 years

First QC Date

August 5, 2025

Last Update Submit

November 17, 2025

Conditions

Keywords

chronic obstructive pulmonary disease (COPD)air pollutionwildfire smoke

Outcome Measures

Primary Outcomes (2)

  • feasibility (by percent of enrolled patients who complete all follow-up assessments)

    % of enrolled patients who complete all follow-up assessments

    30 days

  • fidelity

    electrical sensors on the air cleaners showing the device was on for \>80% of follow-up time

    30 days

Secondary Outcomes (6)

  • average screen-to-enrollment ratio

    Through study completion, an average of 18 months

  • indoor and outdoor PM2.5 concentrations

    30 days

  • respiratory quality of life

    30 days

  • effectiveness

    30 days

  • acceptability

    30 days

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Participants who are randomized into the intervention will receive N95 masks to be worn outdoors and an indoor air cleaner in the room that the participant spends the most time in their home. Both intervention and control arms will receive education.

Device: N95 masks and indoor air cleaner

Control

NO INTERVENTION

Both intervention and control arms will receive education.

Interventions

Participants who are randomized into the intervention will receive N95 masks to be worn outdoors and an indoor air cleaner in the room that the participant spends the most time in their home. Both intervention and control arms will receive education.

Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • KPNC patients
  • enrolled in Care Plus
  • non-smoking
  • oxygen-dependent
  • adults aged ≥65 years old
  • have had membership for at least 1 year prior to data extraction not counting \</=3mo gaps)
  • have known COPD (at least 2 encounters with COPD ICD codes over a 3 year period in the 10 years prior to data extraction using the following ICD codes: ICD-9 491.21, 491.22, 491.8, 491.9, 492.8, 493.2, 493.21, 493.22, 496 and ICD-10 J44.1, J44.0, J41.8, J44.9, J42)15
  • have picked up at least 1 controller inhaler at the pharmacy within 1 year prior to data extraction
  • at least 2 exacerbations of COPD treated in any setting (outpatient or acute care) within 1 year before to data extraction.

You may not qualify if:

  • with \<1 year of continuous membership prior to the date they entered the cohort, allowing for 3-month, non-contiguous gaps
  • any diagnosis with any of the past or present problems: blindness, dementia, deaf or hearing impaired, hospice admission, "tracheostomy" procedure code or problems and/or attached to a ventilator
  • hearing, visually, physically, memory, and/or speech impaired
  • those on the "Do Not Call" list
  • non-English speakers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaiser Permanente Northern California Division of Research

Pleasanton, California, 94588, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

N95 Respirators

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesRespiratory Protective DevicesPersonal Protective EquipmentProtective DevicesSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
data analysts
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: randomized in-home intervention pilot trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 5, 2025

First Posted

August 12, 2025

Study Start

October 7, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

November 20, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

organizational guidance

Locations